European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 148, Issue 2 , Pages 195-198 , February 2010

Efficacy of montelukast, a leukotriene receptor antagonist, for the treatment of dysmenorrhea: A prospective, double-blind, randomized, placebo-controlled study

  • Hiroyuki Fujiwara

      Affiliations

    • Department of Obstetrics and Gynecology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498, Japan
    • ,
  • Ryo Konno

      Affiliations

    • Department of Gynecology, Jichi University Saitama Medical Center, 1-847 Amanuma, Omiya-ku, Saitama 330-8503, Japan
    • ,
  • Sachiho Netsu

      Affiliations

    • Department of Gynecology, Jichi University Saitama Medical Center, 1-847 Amanuma, Omiya-ku, Saitama 330-8503, Japan
    • ,
  • Kohei Odagiri

      Affiliations

    • Department of Obstetrics and Gynecology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498, Japan
    • ,
  • Akiyo Taneichi

      Affiliations

    • Department of Obstetrics and Gynecology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498, Japan
    • ,
  • Satoshi Takamizawa

      Affiliations

    • Department of Obstetrics and Gynecology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498, Japan
    • ,
  • Michitaka Ohwada

      Affiliations

    • Department of Obstetrics and Gynecology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498, Japan
    • ,
  • Mitsuaki Suzuki

      Affiliations

    • Department of Obstetrics and Gynecology, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 285 58 7376; fax: +81 285 44 8505.

Received 6 February 2009 ,Revised 3 September 2009 ,Accepted 30 October 2009.

References 

  1. Jakschik BA, Falkenhein S, Parker CW. Precursor role of arachidonic acid in the release of a slow-reacting substance from rat basophilic leukemia cells. Proc Natl Acad Sci USA. 1977;74:4577–4581
  2. Henderson WR. Eicosanoids and platelet-activating factor in allergic respiratory diseases. Am Rev Respir Dis. 1991;143:S86–S90
  3. Drazen JM, Israel E, O’Byrne PM. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med. 1999;340:197–206
  4. Figueroa DJ, Breyer RM, Defoe SK, et al. Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am J Respir Crit Care Med. 2001;163:226–233
  5. Piper PJ. Pharmacology of leukotrienes. Br Med Bull. 1983;39:225–259
  6. Henderson WR. The role of leukotrienes in inflammation. Ann Intern Med. 1994;121:684–697
  7. Storms W, Michele TM, Knorr B, et al. Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged ≥6 years. Clin Exp Allergy. 2001;31:77–87
  8. Bracken MB, Triche EW, Belanger K, Saftlas A, Beckett WS, Leaderer BP. Asthma symptoms, severity, and drug therapy: a prospective study of effects on 2205 pregnancies. Obstet Gynecol. 2003;102:739–752
  9. Bakhireva LN, Jones KL, Schatz M, et al. Safety of leukotriene receptor antagonists in pregnancy. J Allergy Clin Immunol. 2007;119:618–625
  10. National Heart, Lung, and Blood Institute  National Asthma Education and Prevention Program Asthma and Pregnancy Working Group. NAEPP expert panel report. Managing asthma during pregnancy: recommendations for pharmacologic treatment—2004 update. J Allergy Clin Immunol. 2005;115:34–46
  11. Abu JI, Konje JC. Leukotrienes in gynaecology: the hypothetical value of anti-leukotriene therapy in dysmenorrhoea and endometriosis. Hum Reprod Update. 2000;6:200–205
  12. Chegini N, Rao CV. The presence of leukotriene C4- and prostacyclin-binding sites in nonpregnant human uterine tissue. J Clin Endocrinol Metab. 1988;66:76–87
  13. Demers MY, Hahn DW, McGuire JL. Newer concepts in dysmenorrhoea research: leukotrienes and calcium channel blockers. Premenstrual syndrome and dysmenorrhoea. London: Pitman; 1984;p. 205–213
  14. Rees MC, DiMarzo V, Tippins JR, Morris HR, Turnbull AC. Leukotriene release by endometrium and myometrium throughout the menstrual cycle in dysmenorrhoea and menorrhagia. J Endocrinol. 1987;113:291–295
  15. Nigam S, Benedetto C, Zonca M, Leo-Rossberg I, Lubbert H, Hammerstein J. Increased concentrations of eicosanoids and platelet-activating factor in menstrual blood from women with primary dysmenorrhea. Eicosanoids. 1991;4:137–141
  16. Levinson SL. Peptidoleukotriene binding in guinea pig uterine membrane preparations. Prostaglandins. 1984;28:229–240
  17. Benedetto C. Eicosanoids in primary dysmenorrhea, endometriosis, and menstrual migraine. Gynecol Endocrinol. 1989;3:71–94
  18. Konno R, Fujiwara H, Suzuki M. Effectiveness of leukotriene receptor antagonists for dysmenorrhea and endometriosis. Fam Med. 2004;36:8–9
  19. Harel Z, Riggs S, Vaz R, Flanagan P, Harel D. The use of the leukotriene receptor antagonist montelukast (Singulair) in the management of dysmenorrhea in adolescents. J Pediat Adolesc Gynecol. 2004;17:183–186
  20. Lundström V. Treatment of primary dysmenorrhea with prostaglandin synthetase inhibitors—a promising therapeutic alternative. Acta Obstet Gynecol Scand. 1978;57(5):421–428
  21. Telimaa S, Puolakka J, Ronnberg L, Kauppila A. Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis. Gynecol Endocrinol. 1987;1:13–23
  22. Calhoun WJ, Lavins BJ, Minkwitz MC, Evans R, Gleich GJ, Cohn J. Effect of zafirlukast (Accolate) on cellular mediators of inflammation. Am J Respir Crit Med. 1998;157:1381–1389
  23. Hele DJ, Birrell MA, Webber SE, Foster ML, Belvisi MG. Mediator involvement in antigen-induced bronchospasm and microvascular leakage in the airway of ovalbumin sensitized Brown Norway rats. Br J Pharmacol. 2001;132:481–488
  24. Fujiwara H, Konno R, Netsu S, et al. Localization of mast cells in endometrial cysts. Am J Reprod Immunol. 2004;51:341–344
  25. Harada T, Iwabe T, Terakawa N. Role of cytokines in endometriosis. Fertil Steril. 2001;76:1–10
  26. Wu MY, Ho HN. The role of cytokines in endometriosis. Am J Reprod Immunol. 2003;49:285–296
  27. Ihara T, Uchiide I, Sugamata M. Light and electron microscopic evaluation of antileukotriene therapy for experimental rat endometriosis. Fertil Steril. 2004;81:819–823
  28. Drazen JM, Yandava CN, Dubé L, et al. Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. Nat Genet. 1999;22:168–170
  29. Sampson AP, Siddiqui S, Buchanan D, et al. Variant LTC4 synthase allele modifies cysteinyl leukotriene synthesis eosinophils and predicts clinical response to zafirlukast. Thorax. 2000;55:S28–S31
  30. Brandes JL, Visser WH, Farmer MV, et al. Montelukast for migraine prophylaxis: a randomized, double-blind, placebo-controlled study. Headache. 2004;44:581–586

PII: S0301-2115(09)00646-0

doi: 10.1016/j.ejogrb.2009.10.030

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 148, Issue 2 , Pages 195-198 , February 2010

Article Tools

* Image Usage & Resolution